To proof our hypothesis, we examined the lavage CD8+ T cells from Balb/C mice bearing non-hypermutated, MMR-proficient CT26 colorectal cancer and B6 mice bearing MHCI-low expressing Panc02 pancreatic cancer. The gene discussed is CD8A; the disease is pancreatic neoplasm.